Gout Resource Center

We are pleased to invite you to explore The Rheumatologist’s 2020 coverage of rheumatoid arthritis or systemic lupus erythematosus or gout sessions at ACR Convergence 2020, plus our collection of research reviews, case reports, and clinical articles on advances in the diagnosis and management of rheumatoid arthritis or systemic lupus erythematosus or gout.

Opioids Commonly Prescribed for Gout Attacks

July 9, 2019 • By Reuters Staff

Acute Microcrystalline Arthropathy Masquerades as Infectious Discitis

June 17, 2019 • By Jessita Albert Messiah Dhas, MD, Erik O’Connell, DO, & Lisa L. Schroeder, MD

Contemporary Prevalence of Gout & Hyperuricemia in the U.S.

May 31, 2019 • By Arthritis & Rheumatology

Gout & Sexual Function

April 22, 2019 • By Lara C. Pullen, PhD

Research Is Advancing Our Understanding of Gout & Hyperuricemia

March 19, 2019 • By Lara C. Pullen, PhD

FDA Issues Boxed Warning for Febuxostat & Approves Colchicine for Gout Flare

March 12, 2019 • By Michele B. Kaufman, PharmD, BCGP

Coding Corner Question: Use Level 3 or 4 for RA/Gout Patient?

March 11, 2019 • By From the College

Coding Corner Answer: Use Level 3 or 4 for RA/Gout Patient?

March 11, 2019 • By From the College

AFLAR Experts Discuss Highlights, Hurdles in Rheumatology in Africa

December 18, 2018 • By Thomas R. Collins

Canakinumab Reduces Risk for Gout Flares, But Not Serum Uric Acid Levels

November 26, 2018 • By Lara C. Pullen, PhD